Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP329834.RA-GCdAHqzdDj4fBeuy6W6vdShgulfskfrwBvj1wcfpcE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP329834.RA-GCdAHqzdDj4fBeuy6W6vdShgulfskfrwBvj1wcfpcE130_assertion type Assertion NP329834.RA-GCdAHqzdDj4fBeuy6W6vdShgulfskfrwBvj1wcfpcE130_head.
- NP329834.RA-GCdAHqzdDj4fBeuy6W6vdShgulfskfrwBvj1wcfpcE130_assertion description "[To determine the clinical utility of FISH for del(5q) in MDS/AML, we first compared FISH for 5q31 (EGR1) and 5q33 (CSF1R) in 51 myeloid neoplasms containing del(5q) by metaphase cytogenetics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329834.RA-GCdAHqzdDj4fBeuy6W6vdShgulfskfrwBvj1wcfpcE130_provenance.
- NP329834.RA-GCdAHqzdDj4fBeuy6W6vdShgulfskfrwBvj1wcfpcE130_assertion evidence source_evidence_literature NP329834.RA-GCdAHqzdDj4fBeuy6W6vdShgulfskfrwBvj1wcfpcE130_provenance.
- NP329834.RA-GCdAHqzdDj4fBeuy6W6vdShgulfskfrwBvj1wcfpcE130_assertion SIO_000772 19608274 NP329834.RA-GCdAHqzdDj4fBeuy6W6vdShgulfskfrwBvj1wcfpcE130_provenance.
- NP329834.RA-GCdAHqzdDj4fBeuy6W6vdShgulfskfrwBvj1wcfpcE130_assertion wasDerivedFrom befree-20150227 NP329834.RA-GCdAHqzdDj4fBeuy6W6vdShgulfskfrwBvj1wcfpcE130_provenance.
- NP329834.RA-GCdAHqzdDj4fBeuy6W6vdShgulfskfrwBvj1wcfpcE130_assertion wasGeneratedBy ECO_0000203 NP329834.RA-GCdAHqzdDj4fBeuy6W6vdShgulfskfrwBvj1wcfpcE130_provenance.